R J Bio-Tech
No trades in 1Y
Key Insights
No strengths listed
Weaknesses
1- Company has low interest coverage ratio.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 32.98
- Neutral
- MACD (12,26,9)
- −0.33
- Bearish
- SMA (50)
- 4.30
- Bearish
- SMA (200)
- 7.31
- Bearish
As of , the latest day with price data, so these readings are not current.
Growth Rate
Annual windows: The latest annual results are more than two years old, so no annual growth is shown.
Trailing twelve months: The latest quarterly results are more than a year old.
Quarterly Results
₹ CrResults for the period ended Jun 2018 were due by 14 Aug 2018 and are not in this table yet.
| Particulars | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5 | 7 | 2 | 15 | 11 | 6 | 4 | 0 | 0 | 0 | 7 | 0 | 2 |
| Expenses | 4 | 6 | 2 | 13 | 7 | 4 | 6 | 0 | 11 | 0 | 9 | 0 | 8 |
| Operating Profit | 1 | 2 | 0 | 2 | 4 | 2 | −3 | 0 | −11 | 0 | −1 | 0 | −6 |
| OPM % | 22% | 21% | −22% | 16% | 37% | 33% | −73% | — | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — | −20% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | −374% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 0 | 2 | 0 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0 | 1 | −2 | 1 | 3 | 1 | −4 | 0 | −13 | 0 | −3 | 0 | −17 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — | 0% | — | 0% | — | 0% |
| Net Profit | 0 | 1 | −2 | 1 | 3 | 1 | −4 | 0 | −13 | 0 | −3 | 0 | −17 |
| EPS (₹) | 0.1 | 0.67 | −1.84 | 1.55 | 3.36 | 1.21 | −3.74 | 0 | −13.54 | 0 | −3.54 | 0 | −18.39 |
Profit & Loss
₹ Cr| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.39 | 23.14 | 24.63 | 29.69 | 11.91 | 7.04 | 7.73 | 10.21 | 12.65 | 11.34 | 0 | 0 |
| Expenses | 14.38 | 17.18 | 18.86 | 23.53 | 23.07 | 14.93 | 15.11 | 13.7 | 25.27 | 10.02 | 0.79 | 0.01 |
| Operating Profit | 4.01 | 5.96 | 5.77 | 6.16 | −11.16 | −7.89 | −7.38 | −3.49 | −12.62 | 1.32 | −0.79 | −0.01 |
| OPM % | 21.81% | 25.76% | 23.43% | 20.75% | −93.7% | −112.07% | −95.47% | −34.18% | −99.76% | 11.64% | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0.06 | −8.69 | 0.14 | 0.21 | −2.97 | 0.52 | 0.55 | 0 |
| Interest | 2.34 | 2.64 | 3.6 | 3.44 | 3.6 | 3.89 | 4.14 | 0.78 | 0 | 5.82 | 0 | 0 |
| Depreciation | 0.36 | 0.45 | 0.7 | 0.44 | 0.32 | 0.3 | 0.15 | 0.1 | 0.09 | 0.07 | 0.01 | 0.01 |
| PBT | 1.31 | 2.87 | 1.47 | 2.28 | −15.02 | −20.77 | −11.53 | −4.16 | −15.68 | −4.05 | −0.25 | −0.02 |
| Tax % | 0% | 0% | 0% | 0.44% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 1.3 | 2.87 | 1.46 | 2.27 | −15.02 | −20.77 | −11.53 | −4.16 | −15.68 | −4.05 | −0.25 | −0.01 |
| EPS (₹) | 1.87 | 3.03 | 1.54 | 2.4 | −15.86 | −21.94 | −12.18 | −4.39 | −16.56 | −4.28 | −0.26 | −0.01 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.97 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | — | — |
| Reserves | 7.51 | 12.88 | 14.23 | 16.5 | 1.49 | −19.28 | −30.81 | −34.97 | −50.65 | −59.81 | — | — |
| Borrowings | 19.8 | 24.77 | 26.81 | 24.86 | 29.63 | 37.25 | 41.5 | 42.1 | 40.54 | 51.14 | — | — |
| Other Liabilities | 6.28 | 10.9 | 10.36 | 9.06 | 6.94 | 7.64 | 7.62 | 8.82 | 6.5 | 1.11 | — | — |
| Total Liabilities | 40.56 | 58.02 | 60.87 | 59.89 | 47.53 | 35.08 | 27.78 | 25.42 | 5.86 | 1.91 | — | — |
| Fixed Assets | 2.91 | 2.99 | 2.41 | 2.12 | 1.95 | 1.84 | 1.75 | 1.72 | 1.75 | 1.53 | — | — |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Other Assets | 37.65 | 55.03 | 58.46 | 57.77 | 45.58 | 33.24 | 26.03 | 23.7 | 4.11 | 0.38 | — | — |
| Total Assets | 40.56 | 58.02 | 60.87 | 59.89 | 47.53 | 35.08 | 27.78 | 25.42 | 5.86 | 1.91 | — | — |
Cash Flow
₹ Cr| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 3.88 | −5.12 | 2.47 | 5.79 | 0.07 | −2.69 | 0.84 | 0.71 | 1.96 | −4.72 | 0.7 | −0.8 |
| Investing | −2.37 | −2.18 | −1.66 | −1.35 | −0.84 | −0.82 | −0.77 | −0.67 | −0.37 | 0 | 0.09 | 0 |
| Financing | −2.67 | 7.63 | −0.95 | −4.84 | 0.82 | 3.45 | −0.03 | −0.06 | −1.54 | 4.68 | 0 | 0 |
| Net Cash Flow | −1.16 | 0.33 | −0.14 | −0.4 | 0.05 | −0.05 | 0.04 | −0.02 | 0.05 | −0.04 | 0.79 | −0.8 |
| Free Cash Flow | 3.66 | −5.53 | 2.35 | 5.76 | 0.09 | −2.77 | 0.78 | 0.64 | 1.85 | −4.72 | 0.79 | −0.8 |
| CFO/OP | 101 | −86 | 43 | 94 | −1 | 34 | −11 | −20 | −16 | −386 | −89 | 8,000 |
Ratios
| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 172 | 179 | 238 | 294 | 582 | 863 | 473 | 263 | 23.95 | 9.01 | — | — |
| Inventory Days | 1,123 | 1,198 | 1,368 | 765 | 689 | 637 | 798 | 837 | 30.46 | 0 | — | — |
| Days Payable | 45.83 | 115 | 107 | 63.88 | 54.78 | 157 | 151 | 170 | 11.6 | — | — | — |
| Cash Conversion Cycle | 1,249 | 1,263 | 1,498 | 995 | 1,216 | 1,342 | 1,121 | 930 | 42.8 | 9.01 | — | — |
| Working Capital Days | 237 | 304 | 318 | 276 | 282 | −390 | −892 | −820 | −1,129 | −1,547 | — | — |
| ROCE % | 10.95% | 13.54% | 10.39% | 11.29% | −25.11% | −23.67% | −31.05% | −18.88% | −159.27% | 2400% | — | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view R J Bio-Tech insights
56 extracted metrics across FY13–FY24.
Documents
- 11 Nov 2025
- 3 Sep 2024
- 4 Sep 2023
- 20 Jun 2022
- 16 Jun 2021
- Company update 26 Oct 2024
- Company update 25 Oct 2024
Frequently Asked Questions about R J Bio-Tech
What does R J Bio-Tech Ltd do?
Where is R J Bio-Tech Ltd (RJBIOTECH) listed?
Which sector does R J Bio-Tech Ltd belong to?
Company Information
Incorporated in 2005, R J Biotech Limited develops proprietary hybrids with nutritional and economical traits in Fiber crops, Cereal crops and Vegetable crops
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/536456.md for R J Bio-Tech Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.